Dr. Thaw Tun, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 528 Edward St, Henry, IL 61537 Phone: 309-364-3088 Fax: 309-364-3201 |
News Archive
Rigel Pharmaceuticals, Inc. today announced the initiation of a Phase 3 clinical program for its oral SYK inhibitor, fostamatinib, in patients with ITP (immune thrombocytopenic purpura).
A group of researchers performed a drug repurposing screen on an FDA-approved anti-cancer drug named Mitoxantrone.
A new study conducted at Columbia University Medical Center has revealed some of the underlying mechanisms that may increase the risk of heart disease in people with sleep apnea. The study also found that statins - the cholesterol-lowering medications commonly prescribed to combat heart disease - may help reverse this process.
A tiny capsule invented at a UCLA lab could go a long way toward improving cancer treatment. Devising a method for more precise and less invasive treatment of cancer tumors, a team led by researchers from the UCLA Henry Samueli School of Engineering and Applied Science has developed a degradable nanoscale shell to carry proteins to cancer cells and stunt the growth of tumors without damaging healthy cells.
› Verified 7 days ago